Circadian clock features define novel subtypes among breast cancer cells and shape drug sensitivity

Area of Science:

• Chronobiology
• Cancer Biology
• Pharmacology

Background:

• The circadian clock regulates crucial physiological processes, including DNA damage response.
• Circadian-based therapies offer potential for precision cancer treatment by optimizing drug efficacy and minimizing side effects.
• Current application of these strategies is hindered by limited understanding of clock function across cancer types and its influence on drug response.

Purpose of the Study:

• To investigate the role of the circadian clock in breast cancer.
• To characterize circadian clock phenotypes in breast cancer cell lines.
• To determine the relationship between circadian clock features and anti-cancer drug sensitivity.

Main Methods:

• Deep circadian phenotyping of 14 breast cancer cell lines.
• Development of metrics to assess in vitro circadian rhythm strength and stability.
• Assessment of pharmacological responses to various anti-cancer drugs.

Main Results:

• Identification of four distinct circadian phenotypes: functional, weak, unstable, and dysfunctional clocks.
• Demonstration that the circadian clock significantly influences responses to anti-cancer drugs.
• Identification of specific circadian features correlating with drug sensitivity.

Conclusions:

• The circadian clock is a critical determinant of pharmacological response in breast cancer.
• Circadian phenotypes can be leveraged to predict drug sensitivity.
• Findings provide a foundation for developing circadian-based treatment strategies to optimize breast cancer therapy.